THE ROLE OF LIPOXIN A4 IN CYSTIC FIBROSIS LUNG DISEASE
In Cystic Fibrosis (CF), mutations of the CFTR gene result in defective Cl− secretion and Na+ hyperabsorption by epithelia which leads to airway lumen dehydration and mucus plugging and favours chronic bacterial colonization, persistent inflammation and progressive lung destruction. Beyond this gene...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-03-01
|
Series: | Computational and Structural Biotechnology Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037014601276 |
id |
doaj-caf0734f4a3e44feb70a20fb8b2fd923 |
---|---|
record_format |
Article |
spelling |
doaj-caf0734f4a3e44feb70a20fb8b2fd9232020-11-24T22:18:49ZengElsevierComputational and Structural Biotechnology Journal2001-03702013-03-016710.5936/csbj.201303018THE ROLE OF LIPOXIN A4 IN CYSTIC FIBROSIS LUNG DISEASEValérie Urbach0Gerard Higgins1Paul Buchanan2Fiona Ringholz3National Children's Research Centre, Crumlin, Dublin 12, IrelandNational Children's Research Centre, Crumlin, Dublin 12, IrelandNational Children's Research Centre, Crumlin, Dublin 12, IrelandNational Children's Research Centre, Crumlin, Dublin 12, IrelandIn Cystic Fibrosis (CF), mutations of the CFTR gene result in defective Cl− secretion and Na+ hyperabsorption by epithelia which leads to airway lumen dehydration and mucus plugging and favours chronic bacterial colonization, persistent inflammation and progressive lung destruction. Beyond this general description, the pathogenesis of CF lung disease remains obscure due to an incomplete understanding of normal innate airway defense. This mini-review aims to highlight the role of the pro-resolution lipid mediator, Lipoxin A4, which is inadequately produced in CF, on several aspects of innate immunity that are altered in CF airway disease.http://www.sciencedirect.com/science/article/pii/S2001037014601276 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Valérie Urbach Gerard Higgins Paul Buchanan Fiona Ringholz |
spellingShingle |
Valérie Urbach Gerard Higgins Paul Buchanan Fiona Ringholz THE ROLE OF LIPOXIN A4 IN CYSTIC FIBROSIS LUNG DISEASE Computational and Structural Biotechnology Journal |
author_facet |
Valérie Urbach Gerard Higgins Paul Buchanan Fiona Ringholz |
author_sort |
Valérie Urbach |
title |
THE ROLE OF LIPOXIN A4 IN CYSTIC FIBROSIS LUNG DISEASE |
title_short |
THE ROLE OF LIPOXIN A4 IN CYSTIC FIBROSIS LUNG DISEASE |
title_full |
THE ROLE OF LIPOXIN A4 IN CYSTIC FIBROSIS LUNG DISEASE |
title_fullStr |
THE ROLE OF LIPOXIN A4 IN CYSTIC FIBROSIS LUNG DISEASE |
title_full_unstemmed |
THE ROLE OF LIPOXIN A4 IN CYSTIC FIBROSIS LUNG DISEASE |
title_sort |
role of lipoxin a4 in cystic fibrosis lung disease |
publisher |
Elsevier |
series |
Computational and Structural Biotechnology Journal |
issn |
2001-0370 |
publishDate |
2013-03-01 |
description |
In Cystic Fibrosis (CF), mutations of the CFTR gene result in defective Cl− secretion and Na+ hyperabsorption by epithelia which leads to airway lumen dehydration and mucus plugging and favours chronic bacterial colonization, persistent inflammation and progressive lung destruction. Beyond this general description, the pathogenesis of CF lung disease remains obscure due to an incomplete understanding of normal innate airway defense. This mini-review aims to highlight the role of the pro-resolution lipid mediator, Lipoxin A4, which is inadequately produced in CF, on several aspects of innate immunity that are altered in CF airway disease. |
url |
http://www.sciencedirect.com/science/article/pii/S2001037014601276 |
work_keys_str_mv |
AT valerieurbach theroleoflipoxina4incysticfibrosislungdisease AT gerardhiggins theroleoflipoxina4incysticfibrosislungdisease AT paulbuchanan theroleoflipoxina4incysticfibrosislungdisease AT fionaringholz theroleoflipoxina4incysticfibrosislungdisease AT valerieurbach roleoflipoxina4incysticfibrosislungdisease AT gerardhiggins roleoflipoxina4incysticfibrosislungdisease AT paulbuchanan roleoflipoxina4incysticfibrosislungdisease AT fionaringholz roleoflipoxina4incysticfibrosislungdisease |
_version_ |
1725781393801216000 |